緑内障手術用デバイスの世界市場-2023年～2030年

市場概要

世界の緑内障手術用デバイス市場は、2022年に11億米ドルに達し、2030年には60億米ドルに達することで有利な成長を示すと予測されています。世界の緑内障手術用デバイス市場は、予測期間（2023-2030年）に24.2％のCAGRを示すと予測されています。

緑内障手術用デバイスは、特定の患者の需要に適応した様々な治療の選択肢を提供します。さまざまなデバイスは異なる眼圧管理方法を対象としており、外科医は緑内障のタイプや重症度、患者の解剖学的構造、その他の考慮事項に基づいて最適なデバイスを選択することができます。この個別化により、治療結果と患者の満足度が向上します。

市場力学

低侵襲緑内障手術の増加

低侵襲緑内障手術は、微小侵襲緑内障手術（MIGS）としても知られており、世界の緑内障患者の増加により、この分野の成長が期待されています。例えば、2022年7月、AbbVieは装置メーカーに6,000万米ドルの契約一時金を支払う予定でした。また、将来的にiStarを買収する独占権を取得し、その時点でiStarのMiniJectガジェットの今後の世界の開発と販売のすべてを担当することになります。

MiniJectの埋め込みには低侵襲プロセスが用いられます。緑内障に関係する眼圧を下げるために、眼房と虹彩上腔の間の空間を広げることを目的として、前眼房から角膜に向けて挿入されます。この装置は、緑内障の中で最も患者数の多い開放隅角緑内障専用に設計されています。

老人人口の増加

緑内障は年齢に関係なく発症しますが、高齢者に多く見られます。60歳以上の失明の主な原因の一つです。例えば、緑内障は加齢とともにますます多くなります。世界保健機関（WHO）によると、40歳から80歳の世界人口の3.54％が緑内障であると推定されています。この割合は60歳から80歳では5.47％に増加します。厳しい薬価設定が市場の成長を妨げます。

緑内障と医療機器に対する認識の欠如

病院内では、保健指導の結果か、緑内障の認知度は高いように見えますが、理解度は低く、誤った認識が残っています。患者をよりよく教育し、社会経済的に低いコミュニティを対象とすることを目標に、啓発の中身に重点を置いた啓発プログラムを拡大するための政策調整が必要です。

COVID-19影響分析

COVID-19の流行とそれに伴う景気後退は、選択的手術や治療に使用される機器の世界的需要に大きな影響を与えました。COVID-19が流行する以前は、低侵襲緑内障手術（MIGS）で最も多く利用されていたのはiStent injectで、XENとPreserfloがそれに続いていました。トラベクレクトミーは最も一般的に行われている確立された緑内障手術であるにもかかわらず、COVID-19パンデミックの間は、術後の診察や治療の回数が減るため、トラベクレクトミーの実施頻度は減っています。

ロシア・ウクライナ紛争の影響分析

ロシアとウクライナの紛争は、この地域での普及率が低く、主要な市場プレーヤーが不在であるため、世界の緑内障手術用デバイス市場に中程度の影響を与えると推定・予測されます。しかし、緑内障手術用デバイスの輸出入の影響は、予測期間中、世界の緑内障手術用デバイス市場の成長にほとんど影響を与えないと予測されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 緑内障手術の進歩
    • 眼疾患の有病率の増加
  • 抑制要因
    • 手術費用の高騰
  • 機会
    • 技術的に進歩した治療オプション
  • 影響分析

第5章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 製品タイプ別

• パンチ
• USCマーカー
• USCプレーナー
• USCシェーバー
• プローブ＆アルジャーブラシ
• ダイヤモンドナイフ
• 緑内障ドレナージ器具
• その他

第8章 手術タイプ別

• 低侵襲緑内障手術（MIGS）
• トラベクレクトミー
• チューブシャント挿入術
• 環状光凝固術
• その他

第9章 エンドユーザー別

• 眼科クリニック
• 病院
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Ziemer Ophthalmic Systems AG
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Corza Medical
• Alcon
• Inami & Co., Ltd.
• Katalyst Surgical
• Lumenis
• Millennium Surgical
• Moria Surgical
• Zabbys
• Allergan

第13章 付録

Market Overview

The global glaucoma surgery devices market reached US$ 1.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 6.0 billion by 2030. the global glaucoma surgery devices market is expected to exhibit a CAGR of 24.2% during the forecast period (2023-2030).

Glaucoma surgical devices provide a variety of treatment choices that are adapted to the demands of the particular patient. Different devices target different methods of IOP management, allowing surgeons to select the best appropriate device based on glaucoma type and severity, patient anatomy, and other considerations. This individualization improves therapy results and patient satisfaction.

Market Dynamics

Rise in Minimally Invasive Glaucoma Surgery

Minimally invasive glaucoma surgery is also known as micro-invasive glaucoma surgery (MIGS) and this segment is expected to grow owing to the increasing number of glaucoma patients globally. For instance, In July 2022 AbbVie planned to make the device maker an upfront payment of $60 million. It also acquired the exclusive right to buy iStar in the future, at which point it will be in charge of all future global development and sales of iStar's MiniJect gadget.

A minimally invasive process is used to implant the MiniJect device. It is directed via the anterior chamber of the eye towards the cornea with the goal of increasing space between the chamber and the supraciliary space in order to lower intraocular pressure, which is connected to glaucoma. The gadget is designed exclusively for open-angle glaucoma, the most prevalent kind of illness.

Rise in the Geriatric Population

Glaucoma can occur at any age but is more common in older adults. It is one of the leading causes of blindness for people over the age of 60. For instance, Glaucoma becomes increasingly prevalent with age. According to the World Health Organization (WHO), it is estimated that 3.54% of the global population aged 40 to 80 years has glaucoma. This percentage increases to 5.47% for individuals aged 60 to 80 years. Stringent Pricing of Drugs will Hamper the Growth of the Market.

Lack of Awareness About Glaucoma and the Devices

Glaucoma awareness appears to be high in a hospital population, maybe as a result of clinic health instruction, but understanding remains low and incorrect. There is a need for policy adjustments to expand awareness programmes with a greater emphasis on the substance of the awareness with the goal of better educating patients and targeting lower socioeconomic communities.

COVID-19 Impact Analysis

The COVID-19 pandemic and the ensuing economic downturn have had a substantial impact on global demand for devices used in elective operations and treatments. Prior to the COVID-19 epidemic, the most often utilised MIGS technique in minimally invasive glaucoma surgery (MIGS) was the iStent inject, followed by XEN and Preserflo. Despite the fact that trabeculectomy is the most commonly done established glaucoma surgery, it is being performed less frequently during the COVID-19 pandemic because of the reduced number of postoperative visits and treatments.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global glaucoma surgery devices market, owing to the low prevalence and absence of key market players in this region. however, the impact of the import and export of glaucoma surgery devices is expected to have little influence over the global glaucoma surgery devices market growth over the forecast period.

Segment Analysis

The global glaucoma surgery devices is segmented based on product type, surgery type, end user and region.

Ophthalmic Clinics From End User Segment Accounts for 37.3% of Market Share

Ophthalmic Clinics from the end-user segment with around 37.3% are expected to dominate during the forecast period. The ophthalmology clinics owing to the increased adoption of glaucoma surgical devices, the availability of eye surgeons, and an increase in the focus and expenditure on eye care by ophthalmology clinics.

Geographical Analysis

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period because of the rising prevalence of glaucoma, the growing older population, improved awareness, favourable reimbursement policies, and the existence of numerous important rivals.

Furthermore, glaucoma is becoming increasingly widespread in the United States ageing population. Additionally, increased healthcare spending and well-established infrastructure contribute to the overall growth of the area industry.

For instance, in April 2023 The iTrackTM advanced canaloplasty device has been cleared for sale in the United States by Nova Eye Medical. Nova Eye Medical Limited (Nova Eye Medical), a medical technology company dedicated to advanced ophthalmic treatment technologies and devices, announced that its new canaloplasty device, iTrack, has received FDA 510(k) clearance.

Competitive Landscape

The major global players in the glaucoma surgery devices market include: Ziemer Ophthalmic Systems AG, Corza Medical, Alcon, Inami & Co Ltd, Katalyst Surgical, Lumenis, Millennium Surgical, Moria Surgical, Zabbys, and Allergan among others.

Why Purchase the Report?

• To visualize the global glaucoma surgery devices market segmentation based on product type, surgery type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of glaucoma surgery devices market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global glaucoma surgery devices market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snipper by Surgery Type
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Glaucoma surgery advancements
    • 4.1.1.2. Increase in the prevalence of eye diseases
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Surgery
  • 4.1.3. Opportunity
    • 4.1.3.1. Technologically advanced treatment options
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Punches *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. USC Marker
• 7.4. USC Planer
• 7.5. USC Shaver
• 7.6. Probes & Alger brushes
• 7.7. Diamond Knives
• 7.8. Glaucoma Drainage Devices
• 7.9. Others

8. By Surgery Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
  • 8.1.2. Market Attractiveness Index, By Surgery Type
• 8.2. Minimally Invasive Glaucoma Surgeries (MIGS) *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Trabeculectomy
• 8.4. Tube Shunt Implantation
• 8.5. Cyclophotocoagulation
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Ophthalmic Clinics *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Hospitals
• 9.4. Other

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Spain
    • 10.3.6.5. Italy
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Ziemer Ophthalmic Systems AG *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Corza Medical
• 12.3. Alcon
• 12.4. Inami & Co., Ltd.
• 12.5. Katalyst Surgical
• 12.6. Lumenis
• 12.7. Millennium Surgical
• 12.8. Moria Surgical
• 12.9. Zabbys
• 12.10. Allergan

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us